Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Buprenorphine: its ambiguity]

E Huguet-Levet1

  • 1Université Paris XI, Faculté de Pharmacie, Châtenay Malabry.

Annales Pharmaceutiques Francaises
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Buprenorphine, a partial opioid agonist, is prescribed by some doctors for pain relief or to treat addiction, but some individuals misuse it via injection. Its regulatory status reflects concerns about its misuse potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[Artificial Intelligence in the Pharmaceutical Industry: Governance, Quality, and Regulatory Challenges].

Annales pharmaceutiques francaises·2026
Same journal

No evidence of significant natural environmental exposure to arsenic for Napoleon I on the island of Saint Helena (1815-1821).

Annales pharmaceutiques francaises·2026
Same journal

EFFECTS OF GLP-1 RECEPTOR AGONISTS ON PERIODONTAL TISSUE: AN INTERDISCIPLINARY EVIDENCE MAPPING - SCOPING REVIEW.

Annales pharmaceutiques francaises·2026
Same journal

Regulatory non-compliance of parallel imported medicines in Kenya and implications for public health: Evidence from Nairobi County.

Annales pharmaceutiques francaises·2026
Same journal

Prostaglandin analogues in cosmetic products formulated for eyelash lengthening.

Annales pharmaceutiques francaises·2026
Same journal

Mechanistic and thermodynamic evaluation of sodium citrate-mediated hydrotropism for the biopharmaceutical optimization of BCS Class II drug atorvastatin calcium.

Annales pharmaceutiques francaises·2026
See all related articles

Area of Science:

  • Pharmacology
  • Addiction Medicine

Context:

  • Buprenorphine's unique mu-partial agonist and kappa-antagonist properties differentiate it from pure opioid agonists like morphine.
  • The study examines Buprenorphine prescribing practices and delivery among healthcare providers in the Paris region.

Purpose:

  • To investigate the prescribing patterns and observed uses of Buprenorphine by physicians.
  • To understand how Buprenorphine is accessed and utilized by individuals seeking treatment or misusing the substance.

Summary:

  • Buprenorphine is prescribed by some physicians for its analgesic properties and by others for opioid addiction treatment.
  • A concerning trend observed is the misuse of sublingual Buprenorphine tablets, which are dissolved and injected by some addicts transitioning from heroin.
  • International and national regulations classify Buprenorphine, highlighting its controlled status due to potential for misuse.

Related Experiment Videos

Impact:

  • Highlights the dual-use nature of Buprenorphine, necessitating careful prescribing and monitoring.
  • Informs regulatory bodies and healthcare professionals about the challenges in controlling Buprenorphine diversion and misuse.
  • Underscores the importance of addressing the injection misuse of Buprenorphine in addiction treatment strategies.